Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty

Clinica Chimica Acta

Volumn 302, Issue 1-2, 2000, Pages 161-170

  Ricchiuti, Vincent ^a   Shear, Wendy S ^a   Henry, Timothy D ^a   Paulsen, Pamela R ^a   Miller, Elizabeth A ^a   Apple, Fred S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Angioplasty; Cardiac troponin; Myocardial damage

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CREATINE KINASE; FEMALE; HEART ARREST; HEART DISEASES; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 0033767980     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00365-X     Document Type: Article

References (23)

1. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction
2. Cardiac troponin I. A marker with high specificity for cardiac injury
3. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I
4. Cardiac troponin T in patients with end-stage renal disease: Absence of expression in truncal skeletal muscle
5. The prognostic value of serum troponin T in unstable angina
6. Meta-analysis in clinical chemistry: Validation of cardiac troponin T as a marker for ischemic heart diseases
7. Creatine kinase release after successful percutaneous transluminal coronary angioplasty
8. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty
9. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris
10. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty
11. Troponin T., troponin I and creatine kinase-MB mass after elective coronary stenting
12. Troponin T, troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty
13. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury
14. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting
15. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty
16. Side-branch occlusion during percutaneous transluminal coronary angioplasty
17. Unstable angina classification
18. Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of Benestent trial. Benestent Study Group
19. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
20. Use of cardiac markers as assessed by outcomes analysis
21. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention